Cargando…
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
PURPOSE OF REVIEW: Sinonasal cancers are a heterogenous group of rare cancers for which histopathological diagnosis can be very challenging and treatment options are limited for advanced disease in particular. Here, we review the candidacy of novel diagnostic and prognostic biomarkers, and therapeut...
Autores principales: | Lechner, Matt, Liu, Jacklyn, Lund, Valerie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387318/ https://www.ncbi.nlm.nih.gov/pubmed/32725435 http://dx.doi.org/10.1007/s11912-020-00947-2 |
Ejemplares similares
-
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment
por: Turri-Zanoni, Mario, et al.
Publicado: (2022) -
The Microbiome’s Influence on Head and Neck Cancers
por: Dorobisz, Karolina, et al.
Publicado: (2023) -
Viral and Clinical Oncology of Head and Neck Cancers
por: Goon, Peter, et al.
Publicado: (2022) -
Predictors of Nodal Metastasis in Cutaneous Head and Neck Cancers
por: Han, Albert Y., et al.
Publicado: (2022) -
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity
por: Salinas, Manisha, et al.
Publicado: (2022)